45
DR   Cosmic; 1938695
DR   DepMap; ACH-000026
DR   GEO; GSM136239
DR   IARC_TP53; 30015
DR   KCLB; 80002
DR   LiGeA; CCLE_144
DR   PharmacoDB; 253JBV_15_2019
DR   Wikidata; Q54583655
RX   PubMed=7658585;
RX   PubMed=26589293;
RX   PubMed=29732388;
RX   PubMed=31068700;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice.
CC   Doubling time: 49 +- 5 hours (PubMed=7658585).
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*07:06,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
ST   Source(s): KCLB=80002
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
e leukosis virus producing cell line.";
RL   J. Virol. Methods 121:239-246(2004).
//
occuni P., Di Noto R., Del Vecchio L., Salvatore F., Rotoli B.;
RT   "Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+)
RT   and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+)
RT   lymphoma/leukemia.";
RL   Haematologica 85:496-501(2000).
//
.1182/blood.V70.5.1665.1665;
RA   McCarty T.M., Rajaraman S., Elder F.F.B., Gadson P.F. Jr.,
RA   Thompson E.B.;
RT   "Establishment and characterization of a human myeloid cell line from
RT   Philadelphia chromosome-negative myeloblastic leukemia arising in a
RT   patient with myelodysplastic syndrome.";
RL   Blood 70:1665-1672(1987).
//
ussell E., Johnson B., Buchhagen D.L., Bodner S.M., Phelps R.M.,
RA   Gazdar A.F., Minna J.D.;
RT   "High frequency of somatically acquired p53 mutations in small-cell
RT   lung cancer cell lines and tumors.";
RL   Oncogene 7:339-346(1992).
//